NDC 63545-534

Bovista

Bovista

Bovista is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Lycoperdon Utriforme Fruiting Body.

Product ID63545-534_de36ae16-8f43-0a37-e053-2a95a90ab0d1
NDC63545-534
Product TypeHuman Otc Drug
Proprietary NameBovista
Generic NameBovista
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-05-04
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameLYCOPERDON UTRIFORME FRUITING BODY
Active Ingredient Strength12 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63545-534-01

200 PELLET in 1 VIAL, GLASS (63545-534-01)
Marketing Start Date2022-05-04
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Bovista" or generic name "Bovista"

NDCBrand NameGeneric Name
0220-0895BovistaLYCOPERDON UTRIFORME FRUITING BODY
0220-0896BovistaLYCOPERDON UTRIFORME FRUITING BODY
0220-0897BovistaLYCOPERDON UTRIFORME FRUITING BODY
0220-0900BovistaLYCOPERDON UTRIFORME FRUITING BODY
63545-533BovistaBovista
63545-534BovistaBovista
63545-535BovistaBovista
63545-536BovistaBovista
63545-537BovistaBovista
63545-538BovistaBovista
63545-539BovistaBovista
66096-801BovistaBOVISTA
68428-263BovistaLYCOPERDON UTRIFORME FRUITING BODY
71919-129BovistaLYCOPERDON UTRIFORME FRUITING BODY
69152-1052Bovista 200CBovista
69152-1093Bovista 30CBovista
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.